ASMB vs EXAS · rev $21.6M vs rev $2.76B
Assembly Biosciences Inc (ASMB) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Assembly Biosciences Inc (ASMB) is a biotechnology company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported ASMB revenue for 2026-06-30 was $21.6M. Net income was -$12.9M. ASMB currently screens at market cap $143.0M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ASMB currently screens at market cap $143.0M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the ASMB and EXAS stock pages for the full models.
Not investment advice.